Literature DB >> 10513791

Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines.

.   

Abstract

SLE is a complex disorder with variable presentations, course, and prognosis. Since its prevalence is only 1/1,000, most primary care physicians and general internists will not have sufficient experience in the management of moderate-to-severe life-threatening disease. The major tasks of the primary care physician in the diagnosis and management of patients with SLE include early diagnosis, appropriate referral, monitoring patients with mild, stable disease, and collaboration with a specialist in the management of severe disease. Guidelines for the initial evaluation, reasons for referral, and management of mild and severe SLE are provided.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10513791     DOI: 10.1002/1529-0131(199909)42:9<1785::AID-ANR1>3.0.CO;2-#

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  74 in total

1.  Impact of follow-up visits on disease outcome in Chinese systemic lupus erythematosus.

Authors:  Huanhuan Ma; Jing Dong; Liqin Wang; Lei Zhao; Lin Pan
Journal:  Clin Rheumatol       Date:  2017-08-03       Impact factor: 2.980

Review 2.  Belimumab: in systemic lupus erythematosus.

Authors:  Celeste B Burness; Paul L McCormack
Journal:  Drugs       Date:  2011-12-24       Impact factor: 9.546

3.  Lupus: an overview of the disease and management options.

Authors:  William Maidhof; Olga Hilas
Journal:  P T       Date:  2012-04

Review 4.  Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment.

Authors:  Deana Lazaro
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

5.  [EULAR recommendations for the management of systemic lupus erythematosus].

Authors:  M Schneider
Journal:  Z Rheumatol       Date:  2009-09       Impact factor: 1.372

6.  American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.

Authors:  Bevra H Hahn; Maureen A McMahon; Alan Wilkinson; W Dean Wallace; David I Daikh; John D Fitzgerald; George A Karpouzas; Joan T Merrill; Daniel J Wallace; Jinoos Yazdany; Rosalind Ramsey-Goldman; Karandeep Singh; Mazdak Khalighi; Soo-In Choi; Maneesh Gogia; Suzanne Kafaja; Mohammad Kamgar; Christine Lau; William J Martin; Sefali Parikh; Justin Peng; Anjay Rastogi; Weiling Chen; Jennifer M Grossman
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-06       Impact factor: 4.794

7.  Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment.

Authors:  Cristen B Chafin; Nicole L Regna; Sarah E Hammond; Christopher M Reilly
Journal:  Int Immunopharmacol       Date:  2013-10-09       Impact factor: 4.932

Review 8.  Belimumab: A Review in Systemic Lupus Erythematosus.

Authors:  Hannah A Blair; Sean T Duggan
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

9.  Markers of acute neuropsychiatric systemic lupus erythematosus: a multidisciplinary evaluation.

Authors:  Essam A Abda; Zahraa I Selim; Moustafa E M Radwan; Nagham M Mahmoud; Omar M Herdan; Khalid A Mohamad; Sherifa A Hamed
Journal:  Rheumatol Int       Date:  2012-10-12       Impact factor: 2.631

10.  Choroidopathy and kidney disease: a case report and review of the literature.

Authors:  Nirav V Kamdar; Amsalu Erko; Jason S Ehrlich; Jonathan W Kim; Neeraja Kambham; Glenn M Chertow
Journal:  Cases J       Date:  2009-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.